C L Danning - JoVE Visualize

Showing results (1-10 of 9) with videos related to

Pageof 1

Sort By:

Clinical and Experimental Rheumatology|October 21, 1998

Commonly used disease-modifying antirheumatic drugs in the treatment of inflammatory arthritis: an update on mechanisms of actionC L Danning, D T Boumpas

Current Opinion in Rheumatology|February 4, 1998

Vasculitis associated with primary rheumatologic diseasesC L Danning, G G Illei, D T Boumpas

Arthritis and Rheumatism|June 17, 2000

Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritisC L Danning, G G Illei, C Hitchon, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 10, 1999

CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanismsT Kuroiwa, E G Lee, C L Danning, et al.

The Journal of Rheumatology|June 19, 1998

The effects of delta wave sleep interruption on pain thresholds and fibromyalgia-like symptoms in healthy subjects; correlations with insulin-like growth factor IS A Older, D F Battafarano, C L Danning, et al.

Annals of the Rheumatic Diseases|October 30, 2003

Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effectsK Takada, C L Danning, T Kuroiwa, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2001

IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritisI B McInnes, G G Illei, C L Danning, et al.

Annals of Internal Medicine|August 21, 2001

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritisG G Illei, H A Austin, M Crane, et al.

Arthritis and Rheumatism|April 16, 2002

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studiesG G Illei, K Takada, D Parkin, et al.

Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:

Pageof 1

Clinical and Experimental Rheumatology|October 21, 1998

Commonly used disease-modifying antirheumatic drugs in the treatment of inflammatory arthritis: an update on mechanisms of actionC L Danning, D T Boumpas

Current Opinion in Rheumatology|February 4, 1998

Vasculitis associated with primary rheumatologic diseasesC L Danning, G G Illei, D T Boumpas

Arthritis and Rheumatism|June 17, 2000

Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritisC L Danning, G G Illei, C Hitchon, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 10, 1999

CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanismsT Kuroiwa, E G Lee, C L Danning, et al.

The Journal of Rheumatology|June 19, 1998

The effects of delta wave sleep interruption on pain thresholds and fibromyalgia-like symptoms in healthy subjects; correlations with insulin-like growth factor IS A Older, D F Battafarano, C L Danning, et al.

Annals of the Rheumatic Diseases|October 30, 2003

Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effectsK Takada, C L Danning, T Kuroiwa, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2001

IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritisI B McInnes, G G Illei, C L Danning, et al.

Annals of Internal Medicine|August 21, 2001

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritisG G Illei, H A Austin, M Crane, et al.

Arthritis and Rheumatism|April 16, 2002

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studiesG G Illei, K Takada, D Parkin, et al.

Pageof 1